CREKA-peptide (acetaat)

CREKA peptide acetate is a short peptide sequence, belonging to self-assembling peptides (SAPs), which can self-assemble into functional nanostructures, typically nanofibers, under physiological conditions. CREKA peptide acetate can be used to target tumor cells and tumor vasculature, exhibiting antitumor activity[1].

12352209

Biochemical Assay Reagents

Others

Cancer-programmed cell death

Cancer; Cardiovascular Disease

98.07

CC(O)=O.O=C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCC(O)=O)C(N[C@@H](CCCCN)C(N[C@@H](C)C(O)=O)=O)=O)=O)[C@H](CS)N

C25H47N9O10S

665.76

[1]Zhang N, et al. Recent advances of CREKA peptide-based nanoplatforms in biomedical applications. J Nanobiotechnology. 2023 Mar 3;21 (1) :77.

Blue Ice

-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

http://file.medchemexpress.com/batch_PDF/HY-P10709A/CREKA-peptide-acetate-SDS-MedChemExpress.pdf

Peptides

No Development Reported